The loss of PIK3R1 was more frequently observed in advanced FIGO IIIC-IV stages (34.8%, 47/135) than in FIGO stage I-IIIB cancers (14.5%, 9/62, p = 0.003). Here, PIK3R1 is linked to cancer.